Daclatasvir Api
New Products From This Supplier
We have an extensive series of daclatasvir tablets accessible. We are introducing global marketplace with cheap prices for daclatasvir tablets and interferon alfa 2b injection,interferon alfa 2a/b api,omeprazole sodium for injection,naloxone hydrochloride injection,sodium ozagrel for injection,sofosbuvir,ledipasvir,daclatasvir products created in beijing. If you are exploring for a recognized beijing interferon alfa 2b injection,interferon alfa 2a/b api,omeprazole sodium for injection,naloxone hydrochloride injection,sodium ozagrel for injection,sofosbuvir,ledipasvir,daclatasvir products manufacturer that has speciallized in anti infective drugs & medicines, then Our company is the wonderful option. Our company is a reputable company in beijing that is operating in overall market.
Dosage Form |
Capsule |
Packaging Size |
1x30 |
Packaging Type |
Strip |
Business Nature
Manufacturer
No. Employees
11 - 50 People
Year Established
2012
Annual Turnover
Approx 0.5 Billion US Dollar
Country/Region
Beijing, China
Main Products
Interferon Alfa 2b Injection, Interferon Alfa 2a/b Api, Omeprazole Sodium For Injection, Naloxone Hy...
Legal Status
Have Own Export License
Payment Terms
Bank wire (T/T), Letter of Credit (L/C), MoneyGram, Credit Card (CC), PayPal
Beijing Kawin Technology Share-holding Co., Ltd. can present best quality Medical & Healthcare and various other China interferon alfa 2b injection, interferon alfa 2a/b API, Omeprazole sodium for injection, Naloxone Hydrochloride Injection, Sodium Ozagrel for Injection, sofosbuvir, ledipasvir, daclatasvir products, as they are a famous Manufacturer. The warehouse of Beijing Kawin Technology Share-holding Co., Ltd. is situated in Rongjing East Street Beijing Beijing *** China. Beijing Kawin Technology Share-holding Co., Ltd. is a famous enterprise located in China. Beijing Kawin Technology Share-holding Co., Ltd. Profile Name: Polina
Address: Rongjing East Street Beijing Beijing ***
Country: China
Main Products: interferon alfa 2b injection, interferon alfa 2a/b API, Omeprazole sodium for injection, Naloxone Hydrochloride Injection, Sodium Ozagrel for Injection, sofosbuvir, ledipasvir, daclatasvir
Year Established: 2012
Export Focus: United States
Estimated Employees: 101 - 200 People
Registered Capital: Above US$100 Million
Ownership Status: Private Limited
Export Percentage: 21% - 30%
Factory Size: Below 1, 000 square meters
Production Lines: 6
Research Team Size: 11 - 50 People
Contract Services: Buyer Label Offered